Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q1 2022 · 10-Q
Revenue$9.32M$9.32M−24.4% vs Q1 2021 Net Income-$19.16M-$19.16MN/M vs Q1 2021 EPS Diluted-$0.35-$0.35N/M vs Q1 2021 Gross Profit$4,993,512−43.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flow-$5,468,475N/M Free Cash Flowderived-$5,699,505N/M Margins · derivedGross margin53.6%−18.6 pt vs Q1 2021
Operating margin-269.7%−255.5 pt vs Q1 2021
Net margin-205.5%−129.3 pt vs Q1 2021
ended Dec 31, 2021 · filed Feb 10, 2022 · 41 d after period end